Changes in expression of serine proteases HtrA1 and HtrA2 during estrogen-induced oxidative stress and nephrocarcinogenesis in male Syrian hamster

Acta Biochimica Polonica

Volumn 55, Issue 1, 2008, Pages 9-19

  Zurawa Janicka, Dorota ^a   Kobiela, Jaroslaw ^b   Stefaniak, Tomasz ^b   Wozniak, Agnieszka ^b   Narkiewicz, Joanna ^a   Wozniak, Michał ^b   Limon, Janusz ^b   Lipinska, Barbara ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

17 estradiol; Estrogen induced carcinogenesis; HtrA proteases; Oxidative stress

Indexed keywords

CRICETINAE; MESOCRICETUS AURATUS;

EID: 41549123979     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2008_3123     Document Type: Article

References (45)

1. Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricala C, Amantea A, Noonan DM, Albini A, Natali PG, Lombardi D, Paggi MG (2002) The HtrA1 serine protease is down-regulated during human melanoma progression and repress growth of metastatic melanoma cells. Oncogene 21: 6684-6688.
2. Banerjee SK, Banerjee S, Li SA, Li JJ (1992) Cytogenetic changes in renal neoplasms and during estrogen-induced carcinogensis. In Hormonal Carcinogenesis. Li JJ, Nandi S, Li SA, eds, pp 247-250. Springer-Verlag, New York.
3. Banerjee SK, Banerjee S, Li SA, Li JJ (1994) Induction of chromosomal aberrations in Syrian hamster renal cortical cells by various estrogens. Mutat Res 311: 191-197.
4. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci 100: 3913-3918.
5. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents - dna adducts and mutations. J Natl Cancer Inst Monogr 27: 75-93.
6. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH, Shridhar V (2004) A candidate tumor suppressor HtrA1 is down-regulated in ovarian cancer. Oncogene 23: 1636-1644.
7. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V (2006) Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest 116: 1994-2004.
8. Cilenti L, Lee Y, Hess S, Srinivasula S, Park KM, Junqueira D, Davis H, Bonventre JV, Alnemri ES, Zervos AS (2003) Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. J Biol Chem 278: 11489-11494.
9. Cilenti L, Soundarapandrian MM, Kyriasis GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES, Zervos AS (2004) Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 279: 50295-50301.
10. Clausen T, Southan C, Ehrmann M (2002) The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell 10: 443-455.
11. Felty Q, Roy D (2005) Estrogen, mitochondria, and growth of cancer and non-cancer cells. http://www.carcinogenesis.com/content/4/1/1
12. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, Southan C, Barton A, Fantom KG, West A, Savopoulos J, Hassan NJ, Clinkenbeard H, Hanning C, Amegadzie B, Davis JB, Dingwall C, Livi GP, Creasy CL (2000) Characterization of human HtrA2, novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 267: 5699-5710.
13. Hacker HJ, Vollmer G, Chiquet-Ehrismann R, Bannasch P, Liehr JG (1991) Changes in the cellular phenotype and extracellular matrix during progression of estrogen-induced mesenchymal kidney tumors in Syrian hamster. Cell Pathol 60: 213-223.
14. Hegde R, Srinivasula SM, Zhang ZJ, Wassell R, Mukattash R, Cilenti L, DoBois G, Lazebnik Y, Zevros AS, Fernandes-Alnemri T, Alnemri ES (2002) Identification of Omi/HtrA2 as mitochondrial apoptotic serine protease that disrupts inhibitors of apoptosis protein-caspase interaction. J Biol Chem 277: 432-438.
15. Hodgson AV, Ayala-Torres S, Thompson EB, Liehr JG (1998) Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigenesis. Carcinogenesis 19: 2169-2172.
16. Hu S-I, Carozza M, Klein M, Nantermet P, Luk D, Crowl RM (1998) Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product on osteoarthritic cartilage. J Biol Chem 273: 34406-34412.
17. Jin S, Kalkum M, Overholtzer M, Stoffel A, Chait BT, Levine AJ (2002) CIAP1 and the serine protease HtrA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev 17: 359-367.
18. Jones JM, Datta P, Srinivasula SM, Li W, Gupta S, Zhang Z, Davies E, Hajnoczky G, Saunders TL, Van Kauren ML, Fermandes-Alnemri T, Meisler MH, Alnemri ES (2003) Loss of mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425: 721-727.
19. Kobiela J, Kubasik-Juraniec J, Stefaniak T, Krajewski J, Belleza G, Bucciarelli E, Kryger P, Lachinski A, Gruca Z, Spodnik JH, Wozniak M (2003) The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogensis. Folia Morphol 62: 341-346.
20. Kobiela J, Stefaniak S, Krajewski J, Kalinska-Blach B, Zurawa-Janicka D, Lachinski A, Gackowski D, Olinski R, Nowak J, Knap N, Lipinska B, Sledzinski Z, Wozniak M (2007) Dynamics of estrogen oxidative damage. Acta Biochim Polon 54: 289-295.
21. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685.
22. Li JJ, Li SA (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 46: 1858-1863.
23. Li JJ, Li SA (1990) Estrogen carcinogenesis in hamster tissue: a critical review. Endocrine Rev 11: 524-531.
24. Li JJ, Li SA, Oberley TD, Parsons JA (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res 55: 4347-4351.
25. Li JJ, Hou X, Banerjee SK, Liao D-ZJ, Maggout F, Norris SJ, Li SL (1999) Overexpression and amplification of c-myc in the syrian hamster kidney during estrogen carcinogenesis: a probable critical role on neoplastic transformation. Cancer Res 59: 2340-2346.
26. Li JJ, Veroha SJ, Davis MF, Tawfik O, Hou X, Li SA (2001) ER and PR in renomedullary interstitial cells during syrian hamster estrogen-induced tumorigenesis: evidence for receptor-mediated oncogenesis. Endocrinology 142: 4006-4014.
27. Liehr JG, Sirbasku DA, Jurka E, Randetath K, Randerath E (1988) Inhibition of estrogen-induced renal carcinogenesis in male syrian hamster by tamoxifen without decrease in DNA adduct levels. Cancer Res 48: 779-783.
28. Liehr GJ (1998) Catecholestrogens in the induction of tumors in the kidney of the Syrian hamster. Adv Pharmacol 42: 824-828.
29. Liehr GJ (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocrine Rev 21: 40-54.
30. Liehr GJ (2001) Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7: 273-281.
31. Lipinska B, Zylicz M, Georgopoulos C (1990) The HtrA (DegP) protein, essential for Escherichia coli survival at elevated temperatures, is an endoprotease. J Bacteriol 172: 1791-1797.
32. Mamaeva SE (2002) Atlas of Chromosomes of Human and Animal Cell Lines. Scientific World, Moscow.
33. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy CL, Dingwall C, Downward J (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 277: 439-444.
34. Oberlay TD, Gonzalez A, Lancher LJ, Oberlay LW, Li JJ (1991) Characterization of early lesions in estrogen-induced Syrian hamster. Cancer Res 51: 1922-1929.
35. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soam A, Kanda H, Matsumoto M, Kawaichi M (2004) HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins. Development 131: 1041-1053.
36. Papa D, Li SA, Li J (2003) Comparative genomic hybridization of estrogen-induced ectopic uterine-like stem cell neoplasms in the hamster kidney: nonrandom chromosomal alterations. Mol Carcinog 38: 97-105.
37. Pound JD (1998) Immunochemical protocols. In Methods in Molecular Biology, vol 80. JM Walker JM, ed. Humana Press, New Jersey, Totowa.
38. Roy D, Liehr JG (1999) Estrogen, DNA damage and mutations. Mutat Res 424: 107-115.
39. Seong YM, Choi JY, Park HJ, Kim KJ, Ahn SG, Song GH, Kim IK, Kang S, Rhim H (2004) Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP. J Biol Chem 279: 37588-37596.
40. Shridhar V, Sen A, Chien J, Staub J, avula R, Kovats S, Lee J, Lillie J, Smith DI (2002) Identification of under-expressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 62: 262-270.
41. Srinivasula SM, Gupta S, Datta P, Zhang ZJ, Hedge R, Cheong N, Fernandes-Alnemri T, Alnemri ES (2003) Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem 278: 31469-31472.
42. Stefaniak T, Krajewski J, Kobiela J, Makarewicz W, Stanek A, Asano M, Kondo R, Wakabayashi T, Gruca Z, Wozniak M (2002) Protein oxidation in male Syrian hamster kidney during estrogen-induced carcinogenesis. Pathophysiology 8: 269-273.
43. Verhagen AM, Silke J, Ekert PG, Pakush M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, Vaux DL (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454.
44. Yang QH, Church-Hajduk R, Ren J, Newton NL, Du C (2003) Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAP and facilities caspase activity in apoptosis. Genes Dev 17: 1487-1496.
45. Zumbrunn J, Trueb B (1996) Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398: 187-192.